Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 700-712

  Evans, W S ^a   Anderson, S M ^a   Hull, L T ^a   Azimi, P P ^a   Bowers, C Y ^b   Veldhuis, J D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PLACEBO; RECOMBINANT HORMONE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GROWTH HORMONE RELEASE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PERIODICITY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS;

AGED; CIRCADIAN RHYTHM; ENTROPY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HALF-LIFE; HUMAN GROWTH HORMONE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PLACEBOS; POSTMENOPAUSE; RECOMBINANT PROTEINS; REGRESSION ANALYSIS;

EID: 0035095877     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.2.700     Document Type: Article

References (69)

1. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human
2. Neuroendocrine control of growth hormone secretion
3. GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans
4. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man
5. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: Evidence for relative GHRH deficiency in aging
6. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth-hormone-releasing-hormone (GHRH) pulsatile infusion
7. Fasting levels of growth hormone in men and women
8. Effects of estrogen and sex difference on secretion of human growth hormone
9. Hormonal relationships during the menstrual cycle
10. Studies of the sex-based variation of human growth hormone secretion
11. Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome
12. Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology anti sex-steroid hormone replacement
13. Growth hormone secetion patterns in relation to LH and estradiol secretion throughout normal female puberty
14. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth-hormone (GH) secretion in prepubertal and late adolescent males and females
15. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans
16. An amplitude-specific divergence in the pulsatile mode of GH secretion underlies the gender difference in mean GH concentrations in men and premenopausal women
17. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: Evidence for a stimulatory role of endogenous estrogens during male adolescence
18. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen
19. Sexual dimorphism of growth hormone-releasing hormone and somatostatin gene expression in the hypothalamus of the rat during development
20. Effects of in vivo gonadal hormone environment on in vitro hGRF-40-stimulated GH release
21. Growth hormone secretion in premenopausal women before and after ovariectomy: Effect of hormone replacement therapy
22. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle
23. 2 in young adult men and women
24. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: Comparison to idiopathic short stature and GH deficiency
25. Synergy of L-arginine and growth hormone (GH)-releasing peptide-2 (GHRP-2) on GH release: Influence of gender
26. Repetitive GHRH and arginine administration to explore the maximal secretory capacity of somatotrope cells during lifespan
27. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay
28. Differential impact of age, sexsteroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay
29. Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion
30. Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-hour GH-releasing peptide (GHRP-2) infusion: Pulsatile, entropic, and nyctohemeral mechanisms
31. The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations
32. Deconvolution analysis of neuroendocrine data: Waveform-specific and waveform-independent methods and applications
33. Amplitude modulation of a burst-like mode of cortisol secretion subserves the circadian glucocorticoid rhythm in man
34. Twenty-four hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts
35. Randomness and degrees of irregularity
36. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males
37. Hormone pulsatility discrimination via coarse and short time sampling
38. The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days
39. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release
40. Sexually dimorphic pattem of growth hormone secretion in the elderly
41. Females secrete growth hormone with more process irregularity than males in both human and rat
42. Assessing temporal coupling between two, or among three or more, neuroendocrine pulse trains: Cross-correlation analysis, simulation methods, and conditional probability testing
43. Time-mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations rather than sex, estradiol, or menstrual-cycle stage primarily determine the GH elimination rate in healthy young women and men
44. Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: Relationship to age, pubertal status and body mass
45. Sexual dimorphism in the control of growth hormone secretion
46. Arginine and growth hormonereleasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects
47. Modulation of growth hormonereleasing activity of hexarelin in man
48. Operating behavior of dual or multiple endocrine pulse generators
49. Somatostatin infusion suppresses GH secretory burst number and mass in normal men: A dual mechanism of inhibition
50. Synthetic somatostatin analog (octreotide) suppresses daytime growth hormone secretion equivalently in young and older men: Preserved pituitary responsiveness to somatostatin's inhibition in aging
51. Impact of estrogen on the dose-dependent inhibition by somatostatin of GH secretion in postmenopausal women
52. Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism. Studies in GH-deficient patients and healthy untreated subjects
53. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: An inhibitory feedback effect on GH secretion
54. Multiple levels of cross-talk between somatostatin (SRIF) and growth hormone (GH)-releasing factor in genesis of pulsatile GH secretion
55. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2 driven GH secretion in postmenopausal women
56. Short-term estradiol supplementation augments growth hormone (GH)-secretory responsiveness to dose-varying growth hormone-releasing peptide (GHRP-2) infusions in postmenopausal women
57. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40)
58. Spontaneous oscillations of intracellular calcium and growth hormone secretion
59. A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH) releasing hormone in GH deficient children: Evidence supporting periodic somatostatin secretion
60. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
61. A novel hypothalamic hormone measured in hypophyseal portal plasma drives rapid bursts of GH secretion
62. Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys
63. Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men
64. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone
65. Effects of GRF (1-29) on short-term memory: Neuroendocrine and neuropsychological assessment in healthy young subjects
66. Sleep-promoting effects of growth hormone-releasing hormone in normal men
67. Proposed mechanisms of sex-steroid hormone neuromodulation of the human GH-IGF-I axis
68. Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acid in the rat
69. A switch from oral (2 mg/day) to transdermal (50 μg/day) 17β-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hromone (GH)-substituted women with GH deficiency